Bellevue Life Sciences Acquisition (BLACW) Competitors $0.04 0.00 (0.00%) As of 05/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock BLACW vs. ANSCW, ANSCU, AITRU, AFJKU, AIMBU, AIMAW, AIMAU, ALCYW, ALCYU, and APTMUShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), AI Transportation Acquisition (AITRU), Aimei Health Technology (AFJKU), Aimfinity Investment Corp. I (AIMBU), Aimfinity Investment Corp. I (AIMAW), Aimfinity Investment Corp. I (AIMAU), Alchemy Investments Acquisition Corp 1 (ALCYW), Alchemy Investments Acquisition Corp 1 (ALCYU), and Alpha Partners Technology Merger (APTMU). These companies are all part of the "shell companies" industry. Bellevue Life Sciences Acquisition vs. Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition Aimei Health Technology Aimfinity Investment Corp. I Aimfinity Investment Corp. I Aimfinity Investment Corp. I Alchemy Investments Acquisition Corp 1 Alchemy Investments Acquisition Corp 1 Alpha Partners Technology Merger Agriculture & Natural Solutions Acquisition (NASDAQ:ANSCW) and Bellevue Life Sciences Acquisition (NASDAQ:BLACW) are both financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk. Does the media prefer ANSCW or BLACW? In the previous week, Agriculture & Natural Solutions Acquisition's average media sentiment score of 0.00 equaled Bellevue Life Sciences Acquisition'saverage media sentiment score. Company Overall Sentiment Agriculture & Natural Solutions Acquisition Neutral Bellevue Life Sciences Acquisition Neutral Is ANSCW or BLACW more profitable? Company Net Margins Return on Equity Return on Assets Agriculture & Natural Solutions AcquisitionN/A N/A N/A Bellevue Life Sciences Acquisition N/A N/A N/A Which has better earnings & valuation, ANSCW or BLACW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgriculture & Natural Solutions AcquisitionN/AN/AN/AN/AN/ABellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Does the MarketBeat Community believe in ANSCW or BLACW? Agriculture & Natural Solutions Acquisition and Bellevue Life Sciences Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAgriculture & Natural Solutions AcquisitionN/AN/ABellevue Life Sciences AcquisitionN/AN/A SummaryAgriculture & Natural Solutions Acquisition and Bellevue Life Sciences Acquisition tied by winning 0 of the 0 factors compared between the two stocks. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLACW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLACW vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$361.23M$3.90B$8.03BDividend YieldN/A4.81%4.16%4.23%P/E RatioN/A0.5313.0318.87Price / SalesN/A483.311,707.72106.92Price / CashN/A196.4450.3034.62Price / BookN/A92.043.424.34Net IncomeN/A-$141.08M$1.25B$248.06M7 Day PerformanceN/A0.13%1.19%3.21%1 Month PerformanceN/A33.10%12.31%8.30%1 Year PerformanceN/A15.94%12.27%5.06% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACWBellevue Life Sciences AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/AANSCWAgriculture & Natural Solutions AcquisitionN/A$0.18-2.5%N/A-15.8%$0.00N/A0.00N/APositive NewsANSCUAgriculture & Natural Solutions AcquisitionN/A$10.76-0.3%N/A+4.1%$0.00N/A0.00N/APositive NewsAITRUAI Transportation AcquisitionN/A$11.24flatN/AN/A$0.00N/A0.00N/APositive NewsAFJKUAimei Health TechnologyN/A$11.25+0.3%N/A+8.2%$0.00N/A0.00N/AAIMBUAimfinity Investment Corp. IN/A$16.18-7.5%N/AN/A$0.00N/A0.002AIMAWAimfinity Investment Corp. IN/A$0.07+13.5%N/A+125.0%$0.00N/A0.00N/AGap UpAIMAUAimfinity Investment Corp. IN/A$16.90+4.2%N/AN/A$0.00N/A0.00N/AGap UpALCYWAlchemy Investments Acquisition Corp 1N/A$0.12+9.1%N/A-12.6%$0.00N/A0.00N/AHigh Trading VolumeALCYUAlchemy Investments Acquisition Corp 1N/A$11.38-0.9%N/A+7.0%$0.00N/A0.00N/AHigh Trading VolumeAPTMUAlpha Partners Technology MergerN/A$11.40flatN/A+7.5%$0.00N/A0.002High Trading Volume Related Companies and Tools Related Companies ANSCW Alternatives ANSCU Alternatives AITRU Alternatives AFJKU Alternatives AIMBU Alternatives AIMAW Alternatives AIMAU Alternatives ALCYW Alternatives ALCYU Alternatives APTMU Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLACW) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
